CERS
Price
$1.78
Change
-$0.00 (-0.00%)
Updated
Dec 13, 10:33 AM (EDT)
69 days until earnings call
ICUI
Price
$161.00
Change
-$4.59 (-2.77%)
Updated
Dec 13, 11:51 AM (EDT)
81 days until earnings call
Ad is loading...

CERS vs ICUI

Header iconCERS vs ICUI Comparison
Open Charts CERS vs ICUIBanner chart's image
Cerus
Price$1.78
Change-$0.00 (-0.00%)
Volume$5.14K
CapitalizationN/A
ICU Medical
Price$161.00
Change-$4.59 (-2.77%)
Volume$200
CapitalizationN/A
CERS vs ICUI Comparison Chart
Loading...
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ICUI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CERS vs. ICUI commentary
Dec 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CERS is a Hold and ICUI is a Hold.

COMPARISON
Comparison
Dec 13, 2024
Stock price -- (CERS: $1.78 vs. ICUI: $165.59)
Brand notoriety: CERS and ICUI are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CERS: 54% vs. ICUI: 76%
Market capitalization -- CERS: $342.62M vs. ICUI: $2.55B
CERS [@Medical Specialties] is valued at $342.62M. ICUI’s [@Medical Specialties] market capitalization is $2.55B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CERS’s FA Score shows that 0 FA rating(s) are green whileICUI’s FA Score has 1 green FA rating(s).

  • CERS’s FA Score: 0 green, 5 red.
  • ICUI’s FA Score: 1 green, 4 red.
According to our system of comparison, ICUI is a better buy in the long-term than CERS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CERS’s TA Score shows that 4 TA indicator(s) are bullish while ICUI’s TA Score has 6 bullish TA indicator(s).

  • CERS’s TA Score: 4 bullish, 6 bearish.
  • ICUI’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, ICUI is a better buy in the short-term than CERS.

Price Growth

CERS (@Medical Specialties) experienced а +2.30% price change this week, while ICUI (@Medical Specialties) price change was +6.39% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.76%. For the same industry, the average monthly price growth was -0.44%, and the average quarterly price growth was +1.96%.

Reported Earning Dates

CERS is expected to report earnings on Feb 20, 2025.

ICUI is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Medical Specialties (+0.76% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ICUI($2.55B) has a higher market cap than CERS($343M). ICUI YTD gains are higher at: 66.022 vs. CERS (-17.593). ICUI has higher annual earnings (EBITDA): 253M vs. CERS (-26.34M). ICUI has more cash in the bank: 255M vs. CERS (65.9M). CERS has less debt than ICUI: CERS (96M) vs ICUI (1.7B). ICUI has higher revenues than CERS: ICUI (2.26B) vs CERS (156M).
CERSICUICERS / ICUI
Capitalization343M2.55B13%
EBITDA-26.34M253M-10%
Gain YTD-17.59366.022-27%
P/E RatioN/A333.33-
Revenue156M2.26B7%
Total Cash65.9M255M26%
Total Debt96M1.7B6%
FUNDAMENTALS RATINGS
CERS vs ICUI: Fundamental Ratings
CERS
ICUI
OUTLOOK RATING
1..100
1552
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
92
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9791
PRICE GROWTH RATING
1..100
6143
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CERS's Valuation (47) in the Medical Specialties industry is somewhat better than the same rating for ICUI (92). This means that CERS’s stock grew somewhat faster than ICUI’s over the last 12 months.

CERS's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ICUI (100). This means that CERS’s stock grew similarly to ICUI’s over the last 12 months.

ICUI's SMR Rating (91) in the Medical Specialties industry is in the same range as CERS (97). This means that ICUI’s stock grew similarly to CERS’s over the last 12 months.

ICUI's Price Growth Rating (43) in the Medical Specialties industry is in the same range as CERS (61). This means that ICUI’s stock grew similarly to CERS’s over the last 12 months.

ICUI's P/E Growth Rating (2) in the Medical Specialties industry is significantly better than the same rating for CERS (100). This means that ICUI’s stock grew significantly faster than CERS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CERSICUI
RSI
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
75%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
67%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
63%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
60%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
65%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 5 days ago
69%
Declines
ODDS (%)
Bearish Trend 26 days ago
82%
Bearish Trend 9 days ago
67%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
75%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
66%
View a ticker or compare two or three
Ad is loading...
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ICUI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RSNYX34.77N/A
N/A
Victory Global Energy Transition Y
BRKVX14.44-0.02
-0.14%
MFS Blended Research Em Mkts Eq R6
VGSLX133.41-0.20
-0.15%
Vanguard Real Estate Index Admiral
MTOIX21.02-0.09
-0.43%
NYLI Income Builder Class I
NINDX60.89-0.33
-0.54%
Columbia Large Cap Index Inst

CERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CERS has been loosely correlated with MASS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CERS jumps, then MASS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERS
1D Price
Change %
CERS100%
-1.66%
MASS - CERS
49%
Loosely correlated
-6.19%
FLGT - CERS
45%
Loosely correlated
+0.55%
BNGO - CERS
44%
Loosely correlated
-1.91%
ICUI - CERS
42%
Loosely correlated
-0.36%
CRL - CERS
42%
Loosely correlated
+0.37%
More

ICUI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICUI has been loosely correlated with AXGN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ICUI jumps, then AXGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICUI
1D Price
Change %
ICUI100%
-0.36%
AXGN - ICUI
45%
Loosely correlated
-3.03%
NEOG - ICUI
44%
Loosely correlated
-1.65%
RVTY - ICUI
44%
Loosely correlated
-0.54%
LMAT - ICUI
44%
Loosely correlated
-0.71%
CERS - ICUI
44%
Loosely correlated
-1.66%
More